Form 8-K - Current report:
SEC Accession No. 0001213900-23-067061
Filing Date
2023-08-14
Accepted
2023-08-14 16:15:50
Documents
13
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183383-8k_neuroone.htm   iXBRL 8-K 25026
2 PRESS RELEASE, DATED AUGUST 14, 2023 ea183383ex99-1_neuroone.htm EX-99.1 90333
  Complete submission text file 0001213900-23-067061.txt   297498

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nmtc-20230814.xsd EX-101.SCH 3006
4 XBRL LABEL FILE nmtc-20230814_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE nmtc-20230814_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT ea183383-8k_neuroone_htm.xml XML 3234
Mailing Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344
Business Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344 (952) 426-1383
NEUROONE MEDICAL TECHNOLOGIES Corp (Filer) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-40439 | Film No.: 231170399
SIC: 3841 Surgical & Medical Instruments & Apparatus